Monument Therapeutics, a precision neuroscience company, today announced a further £1M equity investment by the Forster Foundation, a charitable incorporated organisation.
Qkine wins ‘Scale-up of the Year’ at the 2024 Cambridge Independent Business Awards
On the 26th September 2024, Qkine representatives Catherine Elton, CEO and Luana Ferrara, Head of R&D and Collaborations joined some of the most impressive Cambridge business leaders for an exciting evening of networking and entertainment at the Cambridge Independent Business awards ceremony held in the spectacular Great Hall at King’s College, Cambridge.
NK:IO progresses ovarian cancer natural killer therapy
‘We’re building the UK’s first $1tn company’ — Amazon Alexa creator’s new startup
£11.5m to improve semiconductor manufacturing and supply chains
Oxford drug design secures funding to combat cystic fibrosis lung infections
Rovco and Vaarst’s new brand makes €17.8M investment in its fleet
New director unveiled at Sphere Fluidics as company eyes US expansion
PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes
CardiaTec Secures $6.5M Seed Funding to Advance Its Multi-omics Drug Discovery Platform for Cardiovascular Diseases
Qkine expands senior leadership with the appointment of Rob Nixon, Commercial Director, and Paul Grafham, Chief Financial Officer
Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science reagent suppliers, these appointments will support the execution of the company’s growth strategies and expansion of its commercial operations globally.
Paragraf Looks Toward Scaling Up Production of Graphene Devices
VividQ opening US office after taking funding haul past $30m
Abselion announces £1.1m project to develop next-gen cell platform for viral vector production
Biotechnology companies and research organisations in the UK and Canada are entering into a R&D project jointly funded by a 1.1 million GBP grant from Innovate UK and the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). The project is led by VVector Bio and joined by the NRC, Revvity and Abselion.
Hughes Hall honours Chausiaux as Heartfelt Technologies eyes global expansion
Rovco joins Global Wind Energy Council
Rovco, a leader in tech-driven offshore wind solutions, has joined global industry group the Global Wind Energy Council (GWEC). In joining GWEC, Rovco becomes part of a leading community of more than 1,500 companies across 80 countries, collaborating to create a better global policy environment for wind power.
AI projects backed by £32 million to turbocharge productivity
Cambridge drug discovery startup Healx raises £37m
What Library of Things has taught us about behaviour change
Interview with Rovco CEO: New technologies can close huge offshore wind skills gap
New technologies have the ability to massively close the huge skills gap and shortage of workers that is looming over the offshore wind industry, allowing 10 to 17 times more work to be done by one person, according to Brian Allen, CEO of Rovco, a UK company focused on automating offshore wind services by creating and deploying novel tech solutions.